3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
8
Phase 1
5
Phase 3
2
Phase NA
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
39
Pancreatic Neoplasms
27
Rectal Neoplasms
21
Stomach Neoplasms
20
Colonic Neoplasms
16
Esophageal Neoplasms
11
Neoplasm Metastasis
7
Lymphoma, Large B-Cell, Diffuse
7
Gastrointestinal Neoplasms
7
Ovarian Neoplasms
6
Esophageal Squamous Cell Carcinoma
5
Carcinoma, Non-Small-Cell Lung
5
Biliary Tract Neoplasms
5
Adenocarcinoma Of Esophagus
5
Liver Neoplasms
4
Cholangiocarcinoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Advanced Solid Tumors
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Leukemia, Prolymphocytic
2
Glioblastoma
2
Gastrointestinal Diseases
2
Diabetes Mellitus, Insulin-Dependent, 12
2
Interventions
tremelimumab
1
poly(I).poly(c12,U)
1
olaparib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
genexol-PM
1
abagovomab
1
Topotecan
1
Paclitaxel
1
Oxaliplatin
1
MOC31PE immunotoxin
1
LY-2157299
1
Introns
1
Interferon alpha-2
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gefitinib
1
Drug Therapy
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Celecoxib
1
Capecitabine
1
Bevacizumab
1
AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase
1
Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Peritoneal Neoplasms
×
Oxaliplatin
×
Clear all
NCT02604784
2020-09-17
PI-CaP
Fondazione del Piemonte per l'Oncologia
Phase 1/2
Completed
105 enrolled